2024 Q1 Form 10-K Financial Statement

#000165495424002897 Filed on March 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $20.73K $19.90K $122.1K
YoY Change -57.84% -98.08% -96.53%
Cost Of Revenue $26.75K $131.3K $375.8K
YoY Change -73.47% -77.29% -82.22%
Gross Profit -$6.025K -$111.4K -$253.7K
YoY Change -88.34% -124.23% -118.05%
Gross Profit Margin -29.07% -559.85% -207.79%
Selling, General & Admin $1.029M $3.353M $5.635M
YoY Change 35.01% 325.72% -33.98%
% of Gross Profit
Research & Development $2.085M $2.237M $7.317M
YoY Change 22.71% 24.36% 6.89%
% of Gross Profit
Depreciation & Amortization $1.201M $1.221M $328.9K
YoY Change -0.29% -0.35% 12.76%
% of Gross Profit
Operating Expenses $3.114M $5.590M $12.95M
YoY Change 26.52% 116.12% -15.79%
Operating Profit -$3.120M -$5.701M -$13.21M
YoY Change 24.16% 168.09% -5.51%
Interest Expense $48.70K -$50.34K $144.2K
YoY Change 1178.11% 512.41% 169.38%
% of Operating Profit
Other Income/Expense, Net -$194.7K -$266.5K -$563.4K
YoY Change -10740.38% -7112.37% 1748.39%
Pretax Income -$3.315M -$5.924M -$13.77M
YoY Change 31.52% 177.98% -1.69%
Income Tax $800.00 $800.00
% Of Pretax Income
Net Earnings -$3.315M -$5.925M -$13.77M
YoY Change 31.52% 178.01% -1.69%
Net Earnings / Revenue -15991.17% -29771.36% -11276.98%
Basic Earnings Per Share -$0.57
Diluted Earnings Per Share -$0.57 -$1.37 -$3.36
COMMON SHARES
Basic Shares Outstanding 0.000 shares 20.29M shares
Diluted Shares Outstanding 5.771M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.031M $1.886M $1.886M
YoY Change -10.05% 1.74% 1.74%
Cash & Equivalents $1.031M $1.886M $1.886M
Short-Term Investments
Other Short-Term Assets $304.6K $419.5K $419.5K
YoY Change 0.42% 114.27% 114.27%
Inventory $169.7K $167.6K $167.6K
Prepaid Expenses
Receivables $4.172K $455.00 $460.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.509M $2.473M $2.473M
YoY Change -58.46% -13.1% -13.1%
LONG-TERM ASSETS
Property, Plant & Equipment $768.7K $876.6K $876.6K
YoY Change -41.53% -36.28% -36.28%
Goodwill
YoY Change
Intangibles $27.16M $28.28M
YoY Change -13.79%
Long-Term Investments
YoY Change
Other Assets $320.9K $208.8K $208.8K
YoY Change 366.26% 158.83% 158.84%
Total Long-Term Assets $28.25M $29.37M $29.37M
YoY Change -14.6% -14.29% -14.29%
TOTAL ASSETS
Total Short-Term Assets $1.509M $2.473M $2.473M
Total Long-Term Assets $28.25M $29.37M $29.37M
Total Assets $29.75M $31.84M $31.84M
YoY Change -18.94% -14.19% -14.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.286M $1.182M $1.182M
YoY Change 59.55% -2.48% -2.48%
Deferred Revenue $112.6K
YoY Change
Short-Term Debt $312.0K $42.00K $42.00K
YoY Change -54.39% -95.25% -95.25%
Long-Term Debt Due $3.000M $0.00 $0.00
YoY Change 696.75% -100.0% -100.0%
Total Short-Term Liabilities $4.706M $1.337M $1.337M
YoY Change 152.12% -45.94% -45.94%
LONG-TERM LIABILITIES
Long-Term Debt $2.370M $5.922M $5.922M
YoY Change -5.21%
Other Long-Term Liabilities $135.8K $135.8K
YoY Change 1576.9% 1576.91%
Total Long-Term Liabilities $0.00 $135.8K $6.057M
YoY Change -100.0% 1576.9% 74682.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.706M $1.337M $1.337M
Total Long-Term Liabilities $0.00 $135.8K $6.057M
Total Liabilities $7.076M $7.394M $7.394M
YoY Change 61.92% 198.03% 198.03%
SHAREHOLDERS EQUITY
Retained Earnings -$41.20M -$37.89M
YoY Change 54.68% 57.1%
Common Stock $1.528M $46.78K
YoY Change 663.64% -76.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.68M $24.45M $24.45M
YoY Change
Total Liabilities & Shareholders Equity $29.75M $31.84M $31.84M
YoY Change -18.94% -14.19% -14.19%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$3.315M -$5.925M -$13.77M
YoY Change 31.52% 178.01% -1.69%
Depreciation, Depletion And Amortization $1.201M $1.221M $328.9K
YoY Change -0.29% -0.35% 12.76%
Cash From Operating Activities -$1.495M -$1.375M -$4.695M
YoY Change 4.72% 123.36% 55.39%
INVESTING ACTIVITIES
Capital Expenditures $4.428K -$17.02K $92.98K
YoY Change -93.87% -52.68% -85.33%
Acquisitions
YoY Change
Other Investing Activities -$106.9K $1.460K -$8.540K
YoY Change 35516.67% -237.74% -333.97%
Cash From Investing Activities -$111.3K $18.47K -$101.5K
YoY Change 53.53% -47.08% -83.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $777.5K 903.7K $4.924M
YoY Change -2.23% -19533.76% 28.51%
NET CHANGE
Cash From Operating Activities -$1.495M -1.375M -$4.695M
Cash From Investing Activities -$111.3K 18.47K -$101.5K
Cash From Financing Activities $777.5K 903.7K $4.924M
Net Change In Cash -$854.7K -452.5K $32.27K
YoY Change 20.86% -22.67% -68.32%
FREE CASH FLOW
Cash From Operating Activities -$1.495M -$1.375M -$4.695M
Capital Expenditures $4.428K -$17.02K $92.98K
Free Cash Flow -$1.499M -$1.358M -$4.788M
YoY Change -0.03% 134.29% 30.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001014763
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
0 shares
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q4 aimd Accounts Due From Related Parties
AccountsDueFromRelatedParties
0 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4677787 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4002320 shares
CY2022Q4 aimd Convertible Notes Payable Noncurrent Related Party
ConvertibleNotesPayableNoncurrentRelatedParty
0 usd
CY2022Q4 aimd Shares Obligated To Issue
SharesObligatedToIssue
0 shares
CY2022 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2022 aimd Estimated Net Realizable Values
EstimatedNetRealizableValues
235047 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 aimd Effective Income Tax Rate Reconciliation At Deferred Adjustment
EffectiveIncomeTaxRateReconciliationAtDeferredAdjustment
-0.04 pure
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41461
CY2023 dei Entity Registrant Name
EntityRegistrantName
AINOS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1974352
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
8880 Rio San Diego Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste.800
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
CY2023 dei City Area Code
CityAreaCode
858
CY2023 dei Local Phone Number
LocalPhoneNumber
869-2986
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
AIMD
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
5219651 usd
CY2023 dei Auditor Firm
AuditorFirmId
2851
CY2023 dei Auditor Name
AuditorName
KCCW Accountancy Corp.
CY2023 dei Auditor Location
AuditorLocation
Diamond Bar, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1885628 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1853362 usd
CY2022Q4 aimd Accounts Due From Related Parties
AccountsDueFromRelatedParties
177595 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
455 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
201546 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
167593 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
595222 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
419521 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
195787 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2473197 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2845917 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28283208 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32806738 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
876572 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1375676 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
208827 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80683 usd
CY2023Q4 us-gaap Assets
Assets
31841804 usd
CY2022Q4 us-gaap Assets
Assets
37109014 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
112555 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
376526 usd
CY2023Q4 aimd Other Notes Payable Related Party Current
OtherNotesPayableRelatedPartyCurrent
42000 usd
CY2022Q4 aimd Other Notes Payable Related Party Current
OtherNotesPayableRelatedPartyCurrent
884000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1182283 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1212386 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1336838 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2472912 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
2651556 usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
0 usd
CY2023Q4 aimd Convertible Notes Payable Noncurrent Related Party
ConvertibleNotesPayableNoncurrentRelatedParty
2000000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3000000 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q4 aimd Other Notes Payable Related Party Noncurrent
OtherNotesPayableRelatedPartyNoncurrent
270000 usd
CY2022Q4 aimd Other Notes Payable Related Party Noncurrent
OtherNotesPayableRelatedPartyNoncurrent
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
135829 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8096 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7394223 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2481008 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4677787 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4002320 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
46778 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
40023 usd
CY2023Q4 aimd Shares Obligated To Issue
SharesObligatedToIssue
162337 shares
CY2023Q4 aimd Common Stock Issuable
CommonStockIssuable
1623 usd
CY2022Q4 aimd Common Stock Issuable
CommonStockIssuable
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62555808 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58905242 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37886155 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24115606 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-270473 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-201653 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24447581 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34628006 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31841804 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37109014 usd
CY2023 us-gaap Revenues
Revenues
122112 usd
CY2022 us-gaap Revenues
Revenues
3519627 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
375845 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2114284 usd
CY2023 us-gaap Gross Profit
GrossProfit
-253733 usd
CY2022 us-gaap Gross Profit
GrossProfit
1405343 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7317388 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6845964 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5635275 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8535591 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
12952663 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
15381555 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-13206396 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-13976212 usd
CY2023 us-gaap Interest Expense
InterestExpense
144193 usd
CY2022 us-gaap Interest Expense
InterestExpense
53528 usd
CY2023 aimd Gain Loss Issuance Cost Of Convertible Note Measured At Fair Value
GainLossIssuanceCostOfConvertibleNoteMeasuredAtFairValue
-525643 usd
CY2022 aimd Gain Loss Issuance Cost Of Convertible Note Measured At Fair Value
GainLossIssuanceCostOfConvertibleNoteMeasuredAtFairValue
0 usd
CY2023 aimd Fair Value Change Of Senior Secured Convertible Note
FairValueChangeOfSeniorSecuredConvertibleNote
94207 usd
CY2022 aimd Fair Value Change Of Senior Secured Convertible Note
FairValueChangeOfSeniorSecuredConvertibleNote
0 usd
CY2023 us-gaap Other Income
OtherIncome
12276 usd
CY2022 us-gaap Other Income
OtherIncome
23050 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-563353 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30478 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13769749 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14006690 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13770549 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-14006690 usd
CY2023 aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-3.36
CY2022 aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-5.14
CY2023 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4098109 shares
CY2022 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2727458 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13770549 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-14006690 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
68820 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
207453 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13839369 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14214143 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34628006 usd
CY2023 aimd Issuance Of Stock In Exchange Of Vehicle Amount
IssuanceOfStockInExchangeOfVehicleAmount
48559 usd
CY2023 aimd Conversion Of Convertible Notes Payable To Common Stock Amount
ConversionOfConvertibleNotesPayableToCommonStockAmount
274789 usd
CY2023 aimd Issuance Of Stock To Settle Vested Rsus Amount
IssuanceOfStockToSettleVestedRsusAmount
0 usd
CY2023 aimd Issuance Of Stock For Special Stock Bonus Amount
IssuanceOfStockForSpecialStockBonusAmount
1947000 usd
CY2023 aimd Fractional Shares Paid Out In Cash For The Reverse Stock Split Amount
FractionalSharesPaidOutInCashForTheReverseStockSplitAmount
-301 usd
CY2023 aimd Warrants Issued In Connection With Senior Secured Convertible Note Payable
WarrantsIssuedInConnectionWithSeniorSecuredConvertibleNotePayable
19893 usd
CY2023 aimd Conversion Of Senior Secured Convertible Notes To Common Stock Amount
ConversionOfSeniorSecuredConvertibleNotesToCommonStockAmount
254237 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1114767 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13770549 usd
CY2023 aimd Translation Adjustment
TranslationAdjustment
-68820 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24447581 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10197107 usd
CY2022 aimd Issuance Of Stock Upon Public Offering Net Of Issuance Cost Shares
IssuanceOfStockUponPublicOfferingNetOfIssuanceCostShares
1780204 shares
CY2022 aimd Issuance Of Stock To Settle Vested Rsus Amount
IssuanceOfStockToSettleVestedRsusAmount
0 usd
CY2022 aimd Conversion Of Convertible Notes Payable To Common Stock Shares
ConversionOfConvertibleNotesPayableToCommonStockShares
30442959 shares
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6421879 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-14006690 usd
CY2022 aimd Translation Adjustment
TranslationAdjustment
-207453 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34628006 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13770549 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-14006690 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4871057 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4833428 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-286777 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
235047 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1114767 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6421879 usd
CY2023 aimd Stock Issued For Special Stock Bonus
StockIssuedForSpecialStockBonus
-1947000 usd
CY2022 aimd Stock Issued For Special Stock Bonus
StockIssuedForSpecialStockBonus
0 usd
CY2023 aimd Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value
IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue
-525643 usd
CY2022 aimd Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value
IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue
0 usd
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
94207 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-201091 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
201546 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-221767 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
595222 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
223734 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-270411 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
112555 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
121882 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-237003 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4694668 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3040737 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92984 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633823 usd
CY2023 aimd Increase In Other Assets
IncreaseInOtherAssets
8541 usd
CY2022 aimd Increase In Other Assets
IncreaseInOtherAssets
-3645 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101525 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-630178 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
850000 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
800000 usd
CY2023 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
3000000 usd
CY2022 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 usd
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
114026 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023 aimd Repayment Of Other Notes Payable Related Party
RepaymentOfOtherNotesPayableRelatedParty
572000 usd
CY2022 aimd Repayment Of Other Notes Payable Related Party
RepaymentOfOtherNotesPayableRelatedParty
129405 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1780204 usd
CY2023 us-gaap Payments Of Derivative Issuance Costs
PaymentsOfDerivativeIssuanceCosts
390000 usd
CY2022 us-gaap Payments Of Derivative Issuance Costs
PaymentsOfDerivativeIssuanceCosts
0 usd
CY2023 aimd Fractional Shares Paid Out In Cash For The Reverse Stock Split
FractionalSharesPaidOutInCashForTheReverseStockSplit
301 usd
CY2022 aimd Fractional Shares Paid Out In Cash For The Reverse Stock Split
FractionalSharesPaidOutInCashForTheReverseStockSplit
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4923673 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3850799 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-95214 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-78021 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32266 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
101863 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1853362 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1751499 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1885628 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1853362 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
16897 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
43254 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 aimd Convertible Notes Issued To Related Party To Purchase Equipment And Intangible Assets
ConvertibleNotesIssuedToRelatedPartyToPurchaseEquipmentAndIntangibleAssets
0 usd
CY2022 aimd Convertible Notes Issued To Related Party To Purchase Equipment And Intangible Assets
ConvertibleNotesIssuedToRelatedPartyToPurchaseEquipmentAndIntangibleAssets
26000000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
274789 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
30442959 usd
CY2023 aimd Conversion Of Senior Secured Convertible Notes To Common Stock
ConversionOfSeniorSecuredConvertibleNotesToCommonStock
254237 usd
CY2022 aimd Conversion Of Senior Secured Convertible Notes To Common Stock
ConversionOfSeniorSecuredConvertibleNotesToCommonStock
0 usd
CY2023 aimd Issuance Of Common Stock In Exchange Of Vehicle
IssuanceOfCommonStockInExchangeOfVehicle
48559 usd
CY2022 aimd Issuance Of Common Stock In Exchange Of Vehicle
IssuanceOfCommonStockInExchangeOfVehicle
0 usd
CY2023 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
5848 usd
CY2022 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
68635 usd
CY2023 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
1-for-15
CY2023Q4 aimd Exercise Price Of Share
ExercisePriceOfShare
1.00
us-gaap Conversion Of Stock Description
ConversionOfStockDescription
1-for-5
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1885628 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13770549 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37886155 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Significant items subject to estimates and assumptions include useful lives of property and equipment, valuation of stock option, warrants and senior secured convertible notes measured at fair value, undiscounted cash flows used for an impairment testing of intangible assets, inventory losses and sales return. Actual results may differ from these estimates.</p>
CY2023 us-gaap Advertising Expense
AdvertisingExpense
59123 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1950612 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1594637 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1077941 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
889987 usd
CY2022Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
0 usd
CY2023 aimd Stocks Issued During Period Value Conversion Of Convertible Securities
StocksIssuedDuringPeriodValueConversionOfConvertibleSecurities
3000000 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
254237 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-94207 usd
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
2651556 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
92708 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
393253 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1208 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
111119 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
73677 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
90850 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
167593 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
595222 usd
CY2023 aimd Estimated Net Realizable Values
EstimatedNetRealizableValues
235047 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39143975 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39143975 usd
CY2023Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
227009 usd
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
227511 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
39370984 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
39371486 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-11087776 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6564748 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28283208 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32806738 usd
CY2023 aimd Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
4523516 usd
CY2022 aimd Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
4522002 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4534864 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4522512 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4522345 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4521505 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4533858 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5648124 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28283208 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1806854 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1683829 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
930282 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
308153 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
876572 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1375676 usd
CY2023 us-gaap Depreciation
Depreciation
328938 usd
CY2022 us-gaap Depreciation
Depreciation
291706 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
286777 usd
CY2023Q4 aimd Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
0 usd
CY2022Q4 aimd Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
376526 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
42000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
884000 usd
CY2023Q4 aimd Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
270000 usd
CY2022Q4 aimd Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
0 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
2651556 usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
0 usd
CY2023Q4 aimd Convertible Long Term Notes Payable Net
ConvertibleLongTermNotesPayableNet
5963556 usd
CY2022Q4 aimd Convertible Long Term Notes Payable Net
ConvertibleLongTermNotesPayableNet
1260526 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4677787 shares
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.01
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1780000 usd
CY2023Q4 aimd Direct Offering Cost
DirectOfferingCost
1540000 usd
CY2023Q4 aimd Direct Issuing Cost Paid
DirectIssuingCostPaid
1540000 usd
CY2023 aimd Cash Received In Advance
CashReceivedInAdvance
112555 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1114767 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6421879 usd
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
875509 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
6394198 usd
CY2023 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
220723 usd
CY2022 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
24232 usd
CY2023 aimd Cost Of Revenues
CostOfRevenues
18535 usd
CY2022 aimd Cost Of Revenues
CostOfRevenues
3449 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1114767 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6421879 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3373298 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2023 aimd Shares Vested Fair Value
SharesVestedFairValue
745706 usd
CY2022 aimd Shares Vested Fair Value
SharesVestedFairValue
6080095 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
800 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
800 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1573000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2837000 usd
CY2023 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
1573000 usd
CY2022 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
2837000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 aimd Effective Income Tax Rate Reconciliation At Permanent Differences
EffectiveIncomeTaxRateReconciliationAtPermanentDifferences
0 pure
CY2022 aimd Effective Income Tax Rate Reconciliation At Permanent Differences
EffectiveIncomeTaxRateReconciliationAtPermanentDifferences
0 pure
CY2022 aimd Effective Income Tax Rate Reconciliation At Deferred Adjustment
EffectiveIncomeTaxRateReconciliationAtDeferredAdjustment
0 pure
CY2023 aimd Effective Income Tax Rate Reconciliation At State Income Tax Expense
EffectiveIncomeTaxRateReconciliationAtStateIncomeTaxExpense
0 pure
CY2022 aimd Effective Income Tax Rate Reconciliation At State Income Tax Expense
EffectiveIncomeTaxRateReconciliationAtStateIncomeTaxExpense
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.16 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7394000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6480000 usd
CY2023Q4 aimd Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
1025000 usd
CY2022Q4 aimd Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
627000 usd
CY2023Q4 aimd Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
28000 usd
CY2022Q4 aimd Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
0 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
290000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
187000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
232000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
109000 usd
CY2023Q4 aimd Deferred Tax Assets Other Temporary Differences
DeferredTaxAssetsOtherTemporaryDifferences
46000 usd
CY2022Q4 aimd Deferred Tax Assets Other Temporary Differences
DeferredTaxAssetsOtherTemporaryDifferences
60000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9015000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7463000 usd
CY2023Q4 aimd Depreciation Net
DepreciationNet
0 usd
CY2022Q4 aimd Depreciation Net
DepreciationNet
-21000 usd
CY2023Q4 aimd Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
0 usd
CY2022Q4 aimd Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
-21000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9015000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7442000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35211000 usd
CY2023 aimd Description Of Fedral Net Operating Loss Carry Forwards
DescriptionOfFedralNetOperatingLossCarryForwards
The federal net operating loss carryforwards generated through December 31, 2017 of $12,886,000 will expire in 2024 through 2037, while $22,325,000 of federal net operating loss carryforwards generated in post December 31, 2017 or later do not expire due to the provisions in the Tax Cuts and Jobs Act, but may only offset 80% of taxable income in periods of future utilization
CY2023 aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-13770549 usd
CY2022 aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-14006690 usd
CY2023 aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
4098109 shares
CY2022 aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
2727458 shares
CY2023 aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-3.36
CY2022 aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-5.14
CY2023 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
961638 shares
CY2022 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
167332 shares
CY2023 aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
900478 shares
CY2022 aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
193234 shares
CY2023 aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
2197573 shares
CY2022 aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
27904 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4059689 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
388470 shares
CY2023 aimd Totaling
totaling
33002 usd
CY2023 us-gaap Interest Costs Incurred
InterestCostsIncurred
38860 usd
CY2023Q4 aimd Repurchase Agreements Interest Expense Amount1
RepurchaseAgreementsInterestExpenseAmount1
5000000 usd
CY2023Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
12231 shares
CY2023Q2 us-gaap Market Data Revenue
MarketDataRevenue
48559 usd
CY2023Q4 us-gaap Alternative Investment
AlternativeInvestment
52855 usd
CY2024Q1 aimd First Installment Received
FirstInstallmentReceived
777500 usd

Files In Submission

Name View Source Status
0001654954-24-002897-index-headers.html Edgar Link pending
0001654954-24-002897-index.html Edgar Link pending
0001654954-24-002897.txt Edgar Link pending
0001654954-24-002897-xbrl.zip Edgar Link pending
aimd-20231231.xsd Edgar Link pending
aimd_10k.htm Edgar Link pending
aimd_10kimg2.jpg Edgar Link pending
aimd_ex1025.htm Edgar Link pending
aimd_ex1025img189.jpg Edgar Link pending
aimd_ex1025img21.jpg Edgar Link pending
aimd_ex1025img3.jpg Edgar Link pending
aimd_ex1025img45.jpg Edgar Link pending
aimd_ex1025img9.jpg Edgar Link pending
aimd_ex1025img93.jpg Edgar Link pending
aimd_ex231.htm Edgar Link pending
aimd_ex231img1.jpg Edgar Link pending
aimd_ex241.htm Edgar Link pending
aimd_ex311.htm Edgar Link pending
aimd_ex312.htm Edgar Link pending
aimd_ex321.htm Edgar Link pending
aimd_ex322.htm Edgar Link pending
aimd_ex94.htm Edgar Link pending
aimd_ex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
aimd_10k_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aimd-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aimd-20231231_def.xml Edgar Link unprocessable
aimd-20231231_cal.xml Edgar Link unprocessable
aimd-20231231_lab.xml Edgar Link unprocessable